Skip to main content
. 2023 Jan 17;22:14. doi: 10.1186/s12939-022-01816-z

Table 5.

Adjusted prevalence ratio for the metabolic syndrome and its components, according to the quartiles of the percentage of energy consumption from ultra-processed foods percentage energy contribution from the consumption of ultra-processed foods in relation to total energy intake, by quilombola women in the state of Alagoas, Brazil, 2018

Desfechos Quartiles of the percentage of energy consumption from ultra-processed foods p-value
Q1 Q2 Q3 Q4
PR (95% CI) PR (95% CI) PR (95% CI) PR (95% CI)
Arterial hypertension
 Model 1 1.00 1.31 (1.06–1.62) 1.21 (0.97–1.50) 1.16 (0.91–1.49) 0.014a
 Model 2 1.00 1.31 (1.06–1.62) 1.20 (0.97–1.50) 1.16 (0.91–1.49) 0.014a
 Model 3 1.00 1.30 (1.06–1.61) 1.20 (0.97–1.51) 1.17 (0.92–1.48) 0.013a
Diabetes mellitus
 Model 1 1.00 1.22 (0.93–1.60) 1.22 (0.91–1.62) 0.92 (0.66–1.28) 0.612b
 Model 2 1.00 1.21 (0.92–1.60) 1.22 (0.92–1.63) 0.91 (0.66–1.27) 0.601b
 Model 3 1.00 1.21 (0.92–1.58) 1.19 (0.90–1.59) 0.89 (0.64–1.24) 0.498b
Abdominal obesity
 Model 1 1.00 0.98 (0.87–1.11) 0.94 (0.83–1.07) 1.13 (1.01–1.26) 0.038a
 Model 2 1.00 0.98 (0.87–1.11) 0.94 (0.83–1.07) 1.13 (1.01–1.26) 0.038a
 Model 3 1.00 1.04 (0.95–1.13) 1.02 (0.95–1.10) 1.06 (0.98–1.15) 0.136b
HDL low
 Model 1 1.00 0.97 (0.87–1.07) 0.93 (0.83–1.03) 0.95 (0.86–1.06) 0.398b
 Model 2 1.00 0.97 (0.88–1.08) 0.94 (0.84–1.04) 0.96 (0.86–1.06) 0.436b
 Model 3 1.00 0.97 (0.88–1.07) 0.93 (0.83–1.03) 0.96 (0.87–1.07) 0.466b
Hypertriglyceridemia
 Model 1 1.00 0.93 (0.72–1.20) 1.09 (0.86–1.39) 0.98 (0.76–1.28) 0.919b
 Model 2 1.00 0.93 (0.72–1.20) 1.09 (0.86–1.40) 0.96 (0.74–1.25) 0.766b
 Model 3 1.00 0.93 (0.72–1.20) 1.13 (0.89–1.43) 0.98 (0.75–1.27) 0.865b
MetS
 Model 1 1.00 1.02 (0.83–1.24) 1.08 (0.88–1.31) 1.11 (0.89–1.36) 0.340b
 Model 2 1.00 1.02 (0.83–1.24) 1.08 (0.89–1.32) 1.11 (0.90–1.36) 0.418b
 Model 3 1.00 1.03 (0.86–1.24) 1.14 (0.95 -1.37) 1.09 (0.89–1.32) 0.391b

PR Prevalence ratio, 95%CI 95% confidence intervals, Q1 1st quarter, Q2 2 nd quarter, Q3 3rd quarter, Q4 4th quarter, MetS Metabolic syndrome

Model 1: Adjusted for demographic and socioeconomic characteristics whose in the crude analysis showed p ≤ 0.20 (age, race/skin color, marital status, schooling, family participation in a government program, family income, employment status and food insecurity—See Supplementary Table 5)

Model 2: Adjusted for lifestyle and health variables whose in the crude analysis showed p ≤ 0.20 (smoking and health problems in the last 15 days) added to the variables of model 1 that showed p < 0.05 in the analysis for the aforementioned model (these variables were different for each outcome evaluated; only age was present in the analysis for all outcomes)—See Supplementary Table 5

Model 3: Adjusted for anthropometric variables whose in the crude analysis showed p ≤ 0.20 (excess weight and neck circumference) plus the variables from model 1 that showed p < 0.05 in the analysis for the aforementioned model (these variables were different for each outcome evaluated; only age was present in the analysis for all outcomes). The lifestyle and health variables were not part of this final model as they did not present p < 0.05 in the analysis of model 2—See Supplementary Table 5

aValues reported only for the quartile in bold that presented association; bvalues referring to the 4th quartile of each model